Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04712656 · ClinicalTrials.gov registry record
Effects of CPAP Therapy on Blood Pressure and Heart Rate Variability in Obstructive Sleep Apnea
A clinical trial of Sleep Apnea, Obstructive, sponsored by Ohio State University.
- Recruiting
- Registry status
- 1,739
- Enrollment target
- 1
- Study location
NCT04712656: Recruiting study of Sleep Apnea, Obstructive, sponsored by Ohio State University.
NCT04712656 is a study of Sleep Apnea, Obstructive that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 1,739 participants, above the 224-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (676% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04712656, a study of Sleep Apnea, Obstructive, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- 1,739 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to determine whether the effect of continuous positive airway pressure (CPAP) therapy on 24-hour mean blood pressure (BP) in patients with obstructive sleep apnea (OSA) varies between symptom phenotypes.
Primary Outcome
24-hour Mean Blood Pressure obtained from ambulatory blood pressure monitoring (ABPM)
Conditions Studied
Interventions
- DEVICE CPAP therapy
Study Locations (1)
Ohio
- Martha Morehouse Medical Pavilion, Suite 2600 - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,739 participants |
| Start Date | 2021-03-22 |
| Est. Completion | 2032-03-01 |
What NCT04712656 shows while recruiting
NCT04712656 is an observational study that tracks outcomes without assigning an intervention. Its 1,739 participants enrollment target places it among the larger protocols in the corpus, above the 224-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (676% higher).
The record links to 1 condition, with Sleep Apnea, Obstructive appearing as the primary indexed condition, and to 1 intervention - of which CPAP therapy is the first listed.
NCT04712656 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04712656 about?
NCT04712656 is a clinical study titled "Effects of CPAP Therapy on Blood Pressure and Heart Rate Variability in Obstructive Sleep Apnea". The primary objective of this study is to determine whether the effect of continuous positive airway pressure (CPAP) therapy on 24-hour mean blood pressure (BP) in patients with obstructive sleep apnea (OSA) varies between symptom phenotypes.
What is the current status of trial NCT04712656?
This trial is currently recruiting. The enrollment target is 1,739 participants. The study started on 2021-03-22. Estimated completion is 2032-03-01.
What conditions does trial NCT04712656 study?
This clinical trial studies the following conditions: Sleep Apnea, Obstructive.
What interventions are being tested in trial NCT04712656?
The interventions under investigation include: CPAP therapy (DEVICE).
Who is sponsoring clinical trial NCT04712656?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04712656 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Apnea, Obstructive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04712656's enrollment target sits among peer trials
1,739 2nd of 45 the highest of 45 other Sleep Apnea, Obstructive trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Apnea, Obstructive trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nasal vs Oral Breathing in Drug Induced Sleep vs Natural Sleep
RECRUITING
-
Do Endotypes Predict Response and Sequelae in OSA Patients
RECRUITING · Phase 2
-
The PREDICTOR Study: Assessing Diagnostic Predictors of Airway Collapse in Patients With Obstructive Sleep Apnea
RECRUITING · NA
-
Benefits of Oxytocin in Obstructive Sleep Apnea (OSA) Patients Using Continuous Positive Airway Pressure (CPAP) Machine
RECRUITING · Phase 1
-
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
RECRUITING · Phase 3
-
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06413420 · 1,731 participants
SUNOSI® (Solriamfetol) Pregnancy Registry
- NCT05934487 · 1,750 participants · NA
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- NCT06954337 · 1,750 participants · NA
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
- NCT07183527 · 1,750 participants · NA
Hybrid Type I Effectiveness-implementation Cluster Randomized Controlled Trial of CARES
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI